Skip to main navigation Skip to search Skip to main content

First-in-human phase I/II, open-label study of mRNA-2416 alone or combined with durvalumab in patients with advanced solid tumors and ovarian cancer

Ryan J. Sullivan, Oladapo O. Yeku, Deanna Teoh, Shilpa Gupta, Daniela Matei, Andressa S. Laino, Jing Sun, Lili Zhu, Linh Van, Stephanie Pascarella, Sima J. Zacharek, Khanh T. Do, Antonio Jimeno

Research output: Contribution to journal › Article › peer-review

6   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'First-in-human phase I/II, open-label study of mRNA-2416 alone or combined with durvalumab in patients with advanced solid tumors and ovarian cancer'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases